Alnylam Pharmaceuticals, Inc. $ALNY Stock Position Raised by Swedbank AB - MarketBeat
4 hours ago • Google News
Alnylam Pharmaceuticals Inc (ALNY)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 61.07B
P/E Ratio
0.00
Revenue (TTM)
$ 2.46B
Volume
0
52W High
$ 484.21
52W Low
$ 205.87
Dividend Yield
0.00%
Beta
0.32
Technicals
50-Day MA
401.7488
200-Day MA
299.1518
52 Week High
484.21
52 Week Low
205.87
About ALNY
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
Employees
2230
Headquarters
Cambridge, MA
CEO
Dr. Yvonne L. Greenstreet M.B.A., M.D.